Inventor · disambiguated record
John Rothman
Also filed as: ROTHMAN JOHN
24 granted patents·14 pending applications·377 citations·filing 1989–2023
96Inventor score
Top patents by PatentIndex Score
38 records- 0198US10905698B1Methods of treating SARS-COV-2 infectionsTYME INC·Filed 2020·Granted Feb 2, 2021·8 cites·13 claims
- 0297US8114414B2Compositions and methods for treatment of cervical cancerPATERSON YVONNE·Filed 2007·Granted Feb 14, 2012·30 cites·15 claims
- 0396US11633372B2Compositions and methods for treating autismYAMO PHARMACEUTICALS LLC·Filed 2020·Granted Apr 25, 2023·3 cites·18 claims
- 0495US8956621B2Compositions and methods for treatment of cervical dysplasiaPATERSON YVONNE·Filed 2011·Granted Feb 17, 2015·15 cites·26 claims
- 0593US9549973B2Compositions and methods comprising KLK3 or FOLH1 antigenUNIV PENNSYLVANIA·Filed 2014·Granted Jan 24, 2017·16 cites·31 claims
- 0693US5047249ACompositions and methods for treating skin conditions and promoting wound healingMORRIS JOHN CO INC·Filed 1989·Granted Sep 10, 1991·179 cites·34 claims
- 0791US10813901B2Compositions and methods for treating autismYAMO PHARMACEUTICALS LLC·Filed 2018·Granted Oct 27, 2020·3 cites·28 claims
- 0891US9012141B2Compositions and methods comprising KLK3 of FOLH1 antigenPATERSON YVONNE·Filed 2007·Granted Apr 21, 2015·14 cites·15 claims
- 0990US11446369B2Compositions and methods comprising KLK3 or FOLH1 antigenADVAXIS INC·Filed 2019·Granted Sep 20, 2022·3 cites·16 claims
- 1088US9463227B2Listeria-based adjuvantsROTHMAN JOHN·Filed 2012·Granted Oct 11, 2016·18 cites·15 claims
- 1187US10064898B2Listeria-based adjuvantsADVAXIS INC·Filed 2016·Granted Sep 4, 2018·7 cites·14 claims
- 1287USD553544SMotor vehicleDLR PRODUCTS INC·Filed 2006·Granted Oct 23, 2007·66 cites·1 claims
- 1386US12150924B2Compositions and methods for treating autismYAMO PHARMACEUTICALS LLC·Filed 2019·Granted Nov 26, 2024·2 cites·26 claims
- 1483US12453709B2Compositions and methods for treating autismYAMO PHARMACEUTICALS LLC·Filed 2023·Granted Oct 28, 2025·0 cites·21 claims
- 1583US10548876B2Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereofRACE ONCOLOGY LTD·Filed 2018·Granted Feb 4, 2020·3 cites·24 claims
- 1682US10751313B2Compositions and methods for treating autismHOFFMAN TECH LLC·Filed 2018·Granted Aug 25, 2020·5 cites·19 claims
- 1779US9993460B2Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereofRACE ONCOLOGY LTD·Filed 2014·Granted Jun 12, 2018·3 cites·2 claims
- 1875US11931329B2Compositions and methods for treating anxiety-related disordersYAMO PHARMACEUTICALS LLC·Filed 2022·Granted Mar 19, 2024·0 cites·20 claims
- 1975US10500192B2Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereofRACE ONCOLOGY LTD·Filed 2018·Granted Dec 10, 2019·1 cites·5 claims
- 2072US11147800B2Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereofRACE ONCOLOGY LTD·Filed 2019·Granted Oct 19, 2021·0 cites·20 claims
- 2171US11607418B2Methods of treating SARS-CoV-2 infectionsTYME INC·Filed 2021·Granted Mar 21, 2023·0 cites·15 claims
- 2269US11135201B2Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereofRACE ONCOLOGY LTD·Filed 2020·Granted Oct 5, 2021·0 cites·16 claims
- 2367US9974774B2Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereofUPDATE PHARMA INC·Filed 2014·Granted May 22, 2018·1 cites·7 claims
- 2466US11446268B2Compositions and methods for treating anxiety-related disordersYAMO PHARMACEUTICALS LLC·Filed 2020·Granted Sep 20, 2022·0 cites·20 claims
- 2564US2023172951A1Methods of using bile acids to treat viral infectionsHOFFMAN TECH LLC·Filed 2021·Application pending·0 cites
- 2664US2022241368A1Percutaneous anti-microbiota formulationsHOFFMAN TECH LLC·Filed 2022·Application pending·0 cites
- 2760US2015343047A1Compositions and methods for treatment of cervical dysplasiaUNIV PENNSYLVANIA·Filed 2014·Application pending·0 cites
- 2856US2017100469A1Compositions and methods comprising klk3 or folh1 antigenUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 2955US2022288000A1Chewable formulationsHOFFMAN TECH LLC·Filed 2022·Application pending·0 cites
- 3055US2021169903A1Pharmaceutical compositions and methodsTYME INC·Filed 2020·Application pending·0 cites
- 3153US2021275467A1Tumor reduction formulations and methods of use thereofTYME INC·Filed 2019·Application pending·0 cites
- 3252US2021379021A1Method for preparing and delivering bisantrene formulationsRACE ONCOLOGY LTD·Filed 2019·Application pending·0 cites
- 3351US2023165940A1Methods of treating conditions characterized by insulin deficiency in animalsHOFFMAN TECH LLC·Filed 2021·Application pending·0 cites
- 3450US2022211650A1Sustained release formulationsHOFFMAN TECH LLC·Filed 2020·Application pending·0 cites
- 3548US2020282014A1Percutaneous anti-microbiota formulationsHOFFMAN TECH LLC·Filed 2019·Application pending·0 cites
- 3641US2005019552A1Physical and thermal protective coatingFiled 2003·Application pending·0 cites
- 3740US2005288394A1Insulative, emissive and reflective coatingROTHMAN JOHN·Filed 2004·Application pending·0 cites
- 3840US2005287293A1Coated wallboard processROTHMAN JOHN·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Rothman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →